Family-owned drug factories in India erode US generic pricesPost published:August 31, 2017Post category:Industry NewsExpansion by Indian pharma firms is boosting competition in the US, where mergers and pricing wars among drugmakers had already been driving down cost of generics Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostRBI mandates 50% provisioning for NCLT cases Next PostHow Nandan Nilekani returned to Infosys You Might Also Like Insects inspire University of Lincoln’s ULTRACEPT project for anti-collision technology for autonomous vehicles March 15, 2018 IFMR Capital plans fund to invest in firms focused on financial inclusion June 27, 2017 HARTING Biel announces customized 3-D-MID solutions March 6, 2019
Insects inspire University of Lincoln’s ULTRACEPT project for anti-collision technology for autonomous vehicles March 15, 2018